CG Oncology, Inc. (CGON)
57.71
+1.29
(+2.29%)
USD |
NASDAQ |
Feb 20, 16:00
57.71
0.00 (0.00%)
After-Hours: 16:18
CG Oncology Shareholders Equity (Quarterly) : 687.64M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| MannKind Corp. | -44.55M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Denali Therapeutics, Inc. | 926.20M |
| Solid Biosciences, Inc. | 217.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 729.91M |
| Total Liabilities (Quarterly) | 42.27M |
| Debt to Equity Ratio | 0.0105 |
| Current Ratio | 22.79 |
| Net Debt Paydown Yield | -0.04% |